Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000220946 | SCV000279522 | uncertain significance | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (Lek 2016); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Invitae | RCV001273693 | SCV001607510 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001273693 | SCV002045954 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001183517 | SCV002666388 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002509326 | SCV002819576 | likely benign | not specified | 2022-12-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273693 | SCV001457049 | uncertain significance | Microcephaly, normal intelligence and immunodeficiency | 2020-03-10 | no assertion criteria provided | clinical testing |